OLD Category: regulatory biology

miR-155 harnesses Phf19 to potentiate cancer immunotherapy through epigenetic reprogramming of CD8+ T cell fate

• Ji Y et al.

Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial

• Voorwerk L et al.,

Targeting TMEM176B Enhances Antitumor Immunity and Augments the Efficacy of Immune Checkpoint Blockers by Unleashing Inflammasome Activation

• Segovia M et al.,

High‐fat diet intake modulates maternal intestinal adaptations to pregnancy and results in placental hypoxia, as well as altered fetal gut barrier proteins and immune markers

• Gohir W et al.,

Host Genome Variation is Associated with Neurocognitive Outcome in Survivors of Pediatric Medulloblastoma

• Siegel BI et al.,

Proteoglycan signaling in tumor angiogenesis and endothelial cell autophagy

• Gubbiotti MA, Buraschi S, Kapoor A, Iozzo RV

FGF signalling plays similar roles in development and regeneration of the skeleton in the brittle star Amphiura filiformis

• Czarkwiani A et al.,

Potential roles of aquaporin 9 in the pathogenesis of endometriosis

• Choi YS et al.,

Gene expression profiling distinguishes prefibrotic from overtly fibrotic myeloproliferative neoplasms and identifies disease subsets with distinct inflammatory signatures

• Wong WJ et al.,

Host Genome Variation is Associated with Neurocognitive Outcome in Survivors of Pediatric Medulloblastoma

• Siegel BI et al.,

Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma

• Zhang L et al.,

Genomic landscape of tumor-host interactions with differential prognostic and predictive connotations

• Roelands J et al.,